Ralph Weichselbaum
Affiliations: | Radiation and Cellular Oncology | University of Chicago, Chicago, IL |
Google:
"Ralph Weichselbaum"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kirsch DG, Diehn M, Cucinotta FA, et al. (2020) Response Letter: Radiation therapy for COVID-19 pneumopathy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 149: 238-239 |
Hasan Y, Furtado L, Tergas A, et al. (2020) A Phase I trial assessing the safety and tolerability of a therapeutic DNA vaccination against HPV16 and HPV18 E6/E7 oncogenes after chemoradiation for cervical cancer. International Journal of Radiation Oncology, Biology, Physics |
Weichselbaum R, Hellman S. (2020) Abstract PL2: The role of radiotherapy combined with immunotherapy in oligometastatic cancer Cancer Research. 80 |
Wolf S, Schreiber K, Steiner M, et al. (2019) E-102 Destruction of the tumor microenvironment by neoantigen-specific T cells prevents relapse of therapy-resistant cancer variants Jaids Journal of Acquired Immune Deficiency Syndromes. 81: 41 |
Romero-Calvo I, Weber C, Ray M, et al. (2018) Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma Tumors. Molecular Cancer Research : McR |
Hasan Y, Spiotto MT, Furtado LV, et al. (2018) A phase 1/2A trial of synthetic DNA vaccine immunotherapy targeting HPV-16 and -18 after chemoradiation for cervical cancer. Journal of Clinical Oncology. 36: 5525-5525 |
Shukla V, Dalela M, Vij M, et al. (2017) Systemic Delivery of the Tumor Necrosis Factor Gene to Tumors by a Novel Dual Dna-Nanocomplex in a Nanoparticle System. Nanomedicine : Nanotechnology, Biology, and Medicine |
Takahashi H, Jin C, Rajabi H, et al. (2015) MUC1-C activates the TAK1 inflammatory pathway in colon cancer. Oncogene |
Koshy M, Malik R, Spiotto M, et al. (2015) Disparities in treatment of patients with inoperable stage I non-small cell lung cancer: a population-based analysis. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 264-71 |
Widau RC, Parekh AD, Ranck MC, et al. (2014) RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation. Proceedings of the National Academy of Sciences of the United States of America. 111: E484-91 |